www.bloomberg.com Open in urlscan Pro
151.101.65.73  Public Scan

Submitted URL: http://go.pardot.com/e/710433/oking-for-a-bottom-srnd-health/cywh6/473060113?h=843Nz2kLDurhL6neMCbLxWoZmk3BvCZ2XDE5e5...
Effective URL: https://www.bloomberg.com/news/articles/2022-03-22/health-tech-firm-melt-down-leaves-investors-looking-for-a-bottom?srnd=h...
Submission: On March 24 via api from CH — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to content



Skip to content
Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal
Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg
Customer SupportCustomer Support

Bloomberg Webinars: Access a broad range of analysis, research, insight & ideas.

MenuSearch
Bloomberg
Sign InSign OutSubscribe



 * HOME


 * MARKETS


 * TECHNOLOGY


 * POLITICS


 * WEALTH


 * PURSUITS


 * OPINION


 * BUSINESSWEEK


 * NEW ECONOMY


 * EQUALITY


 * GREEN


 * CITYLAB

--------------------------------------------------------------------------------


 * QUICKTAKE


 * BLOOMBERG TV+


 * PODCASTS


 * RADIO


 * BLOOMBERG LIVE

--------------------------------------------------------------------------------


 * NEWSLETTERS


 * WATCHLIST


 * SUBSCRIBE


 * SIGN IN

--------------------------------------------------------------------------------


 * SUBMIT A TIP


 * HELP CENTER


 * LICENSE

Read
 * Bloomberg New Economy
 * Future Finance
 * Wealth
 * Next China
 * Crypto
 * Checkout
 * Hyperdrive
 * Well Spent
 * Prognosis
 * Good Business
 * Billionaires
 * Graphics
 * Sponsored Content
 * Screentime

Watch
 * The David Rubenstein Show
 * The David Rubenstein Wealth Show
 * Art + Technology
 * Future GO

Special Reports
 * Covid-19 Vaccine Tracker
 * What Wall Street Expects for 2021
 * Where to Invest $10,000
 * 50 Companies to Watch
 * Where to Invest $1 Million

Follow
 * Facebook
 * Twitter
 * Instagram
 * LinkedIn


Read
 * Economics
 * Deals
 * Odd Lots
 * The FIX | Fixed Income
 * ETFs
 * FX
 * Factor Investing
 * Alternative Investing
 * Markets Magazine

Watch
 * Daybreak
 * Surveillance
 * Markets
 * What'd You Miss
 * Real Yield
 * Charting Futures
 * Futures in Focus

Follow
 * Twitter
 * Facebook

Data
 * Stocks
 * Currencies
 * Commodities
 * Rates & Bonds
 * Sectors
 * Economic Calendar

SUBSCRIBE
 * Five Things: U.S.
 * Five Things: Europe
 * Five Things: Asia
 * Evening Briefing

Listen
 * What Goes Up
 * Stephanomics
 * Odd Lots
 * Surveillance
 * P&L
 * Trillions


Read
 * Work Shifting
 * Code Wars
 * 5G Network

Special Reports
 * The Elon Musk Tracker
 * Tesla Model 3 Tracker

Watch
 * Bloomberg Technology TV
 * Studio 1.0

Subscribe
 * Fully Charged
 * Power On
 * Game On

Listen
 * Decrypted

Follow
 * Twitter
 * Facebook


Read
 * Election 2020
 * Global Trade Tracker

Listen
 * Sound On
 * Bloomberg Law

Watch
 * Balance of Power

Subscribe
 * Balance of Power

Follow
 * Twitter
 * Facebook


Read
 * Investing
 * Living
 * Opinion & Advice
 * Savings & Retirement
 * Taxes
 * Reinvention

Watch
 * Good Money
 * The David Rubenstein Wealth Show

Listen
 * The Paycheck

Follow
 * Twitter
 * Facebook
 * Instagram


Read
 * Travel
 * Autos
 * Homes
 * Living
 * Culture
 * Style

Special Reports
 * Where to Go in 2021
 * London Property Prices
 * New York Property Prices

Watch
 * Made
 * Traveler
 * Invitation Only

Follow
 * Twitter
 * Facebook
 * Instagram


Read
 * Editorials
 * Letters

Follow
 * Twitter
 * Facebook
 * Instagram

Listen
 * Masters in Business

Subscribe
 * Bloomberg Opinion Today
 * Money Stuff
 * Ritholtz's Reads
 * Early Returns
 * Sparklines


Special Reports
 * Business of Equality
 * The Bloomberg 50
 * Best B-Schools
 * Small Business Survival Guide
 * Working From Home
 * 50 Companies to Watch

The Magazine
 * Subscribe
 * Manage

Follow
 * Twitter
 * Facebook
 * Instagram


Watch
 * New Economy Conversation Series
 * 2020 Digital Program Highlights

Subscribe
 * Turning Points

Listen
 * Stephanomics

Follow
 * Twitter
 * Facebook
 * LinkedIn
 * WeChat


Read
 * Corporate Leadership
 * Capital
 * Society
 * Solutions

Follow
 * Twitter
 * Instagram


Read
 * Science & Energy
 * Climate Adaptation
 * Finance
 * Politics
 * Culture & Design

Special Reports
 * Data Dash

Subscribe
 * Green Daily

Follow
 * Twitter
 * Facebook
 * Instagram


Read
 * Design
 * Culture
 * Transportation
 * Economy
 * Environment
 * Housing
 * Justice
 * Government

Subscribe
 * CityLab Daily
 * MapLab
 * Most Popular

Follow
 * Twitter
 * Facebook
 * Instagram
 * LinkedIn


Live
 * Watch Live TV

Original Series
 * Storylines
 * Moonshot
 * Hello World
 * Good Money
 * Game Changers
 * CityLab Solutions
 * Accelerate
 * See all series...

News Shows
 * Take Charge
 * Take a Break
 * Take the Lead
 * Geo

Follow
 * YouTube
 * Twitter
 * Instagram
 * Facebook


Watch Live TV
 * US
 * Europe
 * Asia
 * Australia
 * Schedule+Shows

Shows
 * Surveillance
 * Daybreak
 * Markets
 * Balance of Power
 * Bloomberg Technology
 * The David Rubenstein Show
 * What'd You Miss?
 * All Shows...

Follow
 * YouTube
 * Twitter
 * Facebook


Listen
 * What Goes Up
 * Stephanomics
 * Odd Lots
 * Foundering
 * Masters in Business
 * Surveillance
 * The Tape
 * Businessweek
 * The Pay Check
 * Prognosis
 * Travel Genius
 * Works for Me
 * Trillions
 * All Podcasts…
 * All Radio Shows…






Markets


HEALTH-TECH MELTDOWN LEAVES INVESTORS LOOKING FOR A BOTTOM

 * Jefferies, Citi recommend focusing on profit-oriented plays
 * Teladoc potential is up for debate in crowded telehealth space

   

Source: Getty Images

By

Cristin Flanagan

+Follow
March 22, 2022, 6:25 PM GMTUpdated onMarch 22, 2022, 8:15 PM GMT


LISTEN TO THIS ARTICLE

2:20


SHARE THIS ARTICLE






Copied
Follow the authors
@CRISTINNARA
+ Get alerts forCristin Flanagan


Out of favor health-care technology stocks may be nearing a bottom.

The selloff in technology firms amid geopolitical turmoil and rising interest
rates spilled over into health-care peers, sending the Global X Telemedicine &
Digital Health ETF to a record low early last week. Since then, though, the ETF
has staged a sharp turnaround, rallying 14%. 




“Weeks like last week suggest a bottom may be forming,” says Glen Santangelo,
analyst at Jefferies Group. He noted a 55% discount to the broader tech sector
-- versus 32% before the pandemic -- could mean there’s some hope for the
heath-care counterpart. 



He expects that stocks focused on turning a profit over growth -- like
revenue-cycle vendor R1 RCM Inc. or health savings accounts manager HealthEquity
Inc.  -- will be rewarded and eventually outperform. The average analyst price
target suggests a 29% upside for R1 RCM over the next 12 months and a roughly 9%
gain in HealthEquity, Bloomberg data show.


 
 


Santangelo is avoiding companies that came to the market via blank check mergers
like Babylon Holdings Ltd., an artificial intelligence-driven symptom checker,
which has fallen more than 50% since its merger last year. Investors are
shunning these companies on their limited disclosures, he said.



Like Santangelo, Citi’s Daniel Grosslight recommends investors focus on pockets
of profitability. Change Healthcare Inc., which is awaiting regulatory clearance
for an $8 billion purchase by UnitedHealth Group Inc., is Grosslight’s top pick.
Even if the deal falls through he is positive on the health-care analytics
software company’s standalone value.



Among other preferred stocks are Teladoc Health Inc. and Health Catalyst Inc.,
which could put up strong performances in the second half, according to
Grosslight. 


 
 

Teladoc, once a pandemic darling and currently retail trading guru Cathie Wood’s
second biggest bet behind Tesla Inc., has plunged more than 75% from February
2021 peak, three months after Wood talked up her bet on a pandemic surge in
virtual care at the Sohn Investor conference. 



Still, Wall Street remains relatively divided on Teladoc, with 19 recommending
buying the stock and 12 saying hold. 

And some strategists warn investors need to tread carefully amid short rebounds
in the market that might be a bear trap.

(Updates with closing prices.)




SHARE THIS ARTICLE






Copied
Follow the authors
@CRISTINNARA
+ Get alerts forCristin Flanagan

Have a confidential tip for our reporters?
Get in touch
Before it's here, it's on the
Bloomberg Terminal
Learn more


LIVE ON BLOOMBERG
Watch Live TVListen to Live Radio
Video Player is loading.
Play Video
Play
Unmute

Current Time 0:00
/
Duration 0:00
Loaded: 0%

0:00
Progress: 0%
Stream Type LIVE
Remaining Time -0:00
 
Playback Rate

1x
Chapters
 * Chapters

Captions
 * captions settings, opens captions settings dialog
 * captions off, selected

Fullscreen

This is a modal window.



Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.


Play Again




Terms of Service Manage Cookies Trademarks Privacy Policy ©2022 Bloomberg L.P.
All Rights Reserved
Careers Made in NYC Advertise Ad Choices Help


Your monthly limit of free content is about to expire. Stay on top of historic
market volatility. Try 3 months for $8.75 $0.50 per week. Cancel anytime.
Claim This Offer
Sign In
Bloomberg Anywhere clients get free access